Glenmark PharmaceuticalsGLENMARK 
$18.220.58%24h
0.58%24h
Global rank2589
Market cap$5.14B
Change 7d0.12%
YTD Performance81.57%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Glenmark Pharmaceuticals (GLENMARK)
As of December 2024, Glenmark Pharmaceuticals has a market cap of $5.14B. This makes Glenmark Pharmaceuticals the world's 2589th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Glenmark Pharmaceuticals from 2002 to 2024
-
Value:-
Market cap history of Glenmark Pharmaceuticals from 2002 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $2.69B | -5.12% |
| 2023 | $2.83B | 101.33% |
| 2022 | $1.41B | -19.75% |
| 2021 | $1.75B | 7.10% |
| 2020 | $1.64B | 42.03% |
| 2019 | $1.15B | -49.87% |
| 2018 | $2.30B | 16.53% |
| 2017 | $1.97B | -33.06% |
| 2016 | $2.95B | -3.63% |
| 2015 | $3.06B | 19.70% |
| 2014 | $2.55B | 44.27% |
| 2013 | $1.77B | 1.00% |
| 2012 | $1.75B | 80.05% |
| 2011 | $973.34M | -18.93% |
| 2010 | $1.20B | 31.27% |
| 2009 | $914.65M | -6.84% |
| 2008 | $981.80M | -50.32% |
| 2007 | $1.98B | 295.55% |
| 2006 | $499.60M | 92.22% |
| 2005 | $259.91M | 29.33% |
| 2004 | $200.98M | 238.85% |
| 2003 | $59.31M | 1391.25% |
| 2002 | $3.98M | - |
GLENMARK Market Cap Today is $5.14B 0.58% - 24 Dec 2024
View largest stocks by market cap 
